Halozyme Therapeutics shares owned by Point72 Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Point72 Asset Management
from 13F filings
Historical chart of Point72 Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Point72 Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $4.1M | 85k | 47.81 |
| 2023-09-30 | $1.2M | 32k | 38.20 |
| 2023-06-30 | $14M | 380k | 36.07 |
| 2023-03-31 | $15M | 383k | 38.19 |
| 2022-12-31 | $6.9M | 122k | 56.90 |
| 2022-09-30 | $12M | 304k | 39.54 |
| 2022-03-31 | $10M | 259k | 39.88 |
| 2021-12-31 | $8.5M | 212k | 40.21 |
| 2020-12-31 | $1.8M | 42k | 42.70 |
| 2020-09-30 | $2.6M | 98k | 26.28 |
| 2020-06-30 | $2.1M | 77k | 26.82 |
| 2020-03-31 | $3.3M | 183k | 17.99 |
| 2019-06-30 | $20M | 1.2M | 17.18 |
| 2016-12-31 | $5.8M | 582k | 9.88 |